日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Letter to the editor: Relevant errors in a systematic review and network meta-analysis evaluating the efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia

致编辑的信：系统评价和网络荟萃分析中评估不同药物干预治疗迟发性运动障碍的疗效和安全性的相关错误

期刊:European Journal of Clinical Pharmacology
影响因子:2.7
doi:10.1007/s00228-025-03826-6
Correll, Christoph U; Rowe, David; Ribalov, Rinat; Campos, Verena Ramirez; Solmi, Marco
发表日期：2025
文献求助 收藏

Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies

fremanezumab 对发作性和慢性偏头痛患者残疾结局的影响：一项 3 期研究的汇总分析

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-022-01438-4
McAllister, Peter; Cohen, Joshua M; Campos, Verena Ramirez; Ning, Xiaoping; Janka, Lindsay; Barash, Steve
偏头痛
神经科学
发表日期：2022
文献求助 收藏

Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

更正：弗瑞马珠单抗治疗≥60岁发作性或慢性偏头痛临床试验参与者的疗效和安全性：3项随机、双盲、安慰剂对照3期研究的汇总结果

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-022-01423-x
Nahas, Stephanie J; Naegel, Steffen; Cohen, Joshua M; Ning, Xiaoping; Janka, Lindsay; Campos, Verena Ramirez; Krasenbaum, Lynda J; Holle-Lee, Dagny; Kudrow, David; Lampl, Christian
偏头痛
神经科学
发表日期：2022
文献求助 收藏

Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies

fremanezumab治疗发作性及慢性偏头痛患者的安全性和耐受性：一项3期研究的汇总分析

期刊:Cephalalgia
影响因子:4.6
doi:10.1177/03331024221076485
Diener, Hans Christoph; McAllister, Peter; Jürgens, Tim P; Kessler, Yoel; Ning, Xiaoping; Cohen, Joshua M; Campos, Verena Ramirez; Barash, Steve; Silberstein, Stephen D
偏头痛
神经科学
发表日期：2022
文献求助 收藏

Commentary: Constipation caused by anti-calcitonin gene-related peptide migraine therapeutics explained by antagonism of calcitonin gene-related peptide's motor-stimulating and prosecretory function in the intestine

评论：抗降钙素基因相关肽偏头痛药物引起的便秘，可解释为该类药物拮抗了降钙素基因相关肽在肠道中的运动刺激和促分泌功能。

期刊:Frontiers in Physiology
影响因子:3.4
doi:10.3389/fphys.2022.1067274
Mackenzie, Kimberly D; Ortega, Mario; Kessler, Yoel; Campos, Verena Ramirez; Krasenbaum, Lynda J; Carr, Karen; Ning, Xiaoping; Stratton, Jennifer
偏头痛
神经科学
发表日期：2022
文献求助 收藏

Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies

弗瑞马珠单抗治疗≥60岁发作性或慢性偏头痛临床试验参与者的疗效和安全性：3项随机、双盲、安慰剂对照3期研究的汇总结果

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-021-01351-2
Nahas, Stephanie J; Naegel, Steffen; Cohen, Joshua M; Ning, Xiaoping; Janka, Lindsay; Campos, Verena Ramirez; Krasenbaum, Lynda J; Holle-Lee, Dagny; Kudrow, David; Lampl, Christian
偏头痛
神经科学
发表日期：2021
文献求助 收藏

Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study

年龄和性别对难治性偏头痛患者使用弗瑞马珠单抗疗效的影响：随机、安慰剂对照、3b期FOCUS研究的结果

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-021-01336-1
MaassenVanDenBrink, Antoinette; Terwindt, Gisela M; Cohen, Joshua M; Barash, Steve; Campos, Verena Ramirez; Galic, Maja; Ning, Xiaoping; Kärppä, Mikko
偏头痛
神经科学
发表日期：2021
文献求助 收藏

Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial

弗瑞马珠单抗治疗对既往预防性治疗反应不足的偏头痛患者的疗效和安全性：一项随机、安慰剂对照试验按国家/地区进行的亚组分析

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-021-01232-8
Spierings, Egilius L H; Kärppä, Mikko; Ning, Xiaoping; Cohen, Joshua M; Campos, Verena Ramirez; Yang, Ronghua; Reuter, Uwe
偏头痛
神经科学
发表日期：2021
文献求助 收藏

Immunogenicity of biologic therapies for migraine: a review of current evidence

偏头痛生物疗法的免疫原性：现有证据综述

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-020-01211-5
Cohen, Joshua M; Ning, Xiaoping; Kessler, Yoel; Rasamoelisolo, Michele; Campos, Verena Ramirez; Seminerio, Michael J; Krasenbaum, Lynda J; Shen, Honglue; Stratton, Jennifer
偏头痛
神经科学
免疫/内分泌
发表日期：2021
文献求助 收藏

Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study

在 3b 期 FOCUS 研究中，评估了 fremanezumab 对接受 2 至 4 类偏头痛预防药物治疗 6 个月后疗效不佳的发作性偏头痛和慢性偏头痛患者的疗效和安全性。

期刊:Journal of Headache and Pain
影响因子:7.9
doi:10.1186/s10194-021-01279-7
Ashina, Messoud; Cohen, Joshua M; Galic, Maja; Campos, Verena Ramirez; Barash, Steve; Ning, Xiaoping; Kessler, Yoel; Janka, Lindsay; Diener, Hans-Christoph
偏头痛
神经科学
发表日期：2021
文献求助 收藏